5 days Ago By Defense World Staff
Virtu Financial LLC increased its stake in shares of Azitra, Inc. (NYSEAMERICAN:AZTR – Free Report) by 196.4% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC).
The institutional investor owned 63,180 shares of the company’s stock after acquiring an additional 41,866 shares during the quarter. Virtu Financial LLC owned about 0.83% of Azitra worth $27,000 at the end of the most recent quarter.
Azitra Stock Down 4.3 %AZTR stock opened at $0.29 on Wednesday.
The firm has a fifty day simple moving average of $0.33. Azitra, Inc.
has a 12 month low of $0.23 and a 12 month high of $12.00.
About Azitra (Free Report)Azitra, Inc, an early-stage biopharmaceutical company, develops therapies for precision dermatology using engineered proteins and live biotherapeutic products to treat skin diseases. It develops ATR-12, a genetically modified strain of S. epidermidis, which is in Phase Ib clinical trial for treating Netherton syndrome, a skin disease.
Further ReadingFive stocks we like better than AzitraWhat is a buyback in stocks? A comprehensive guide for investorsD-Wave: Multiple Use Cases Emerge Following Quantum SupremacyUnveiling The Power Of VWAP: A Key Indicator For TradersAmazon Falls Back to a Key Support Line: Here’s How to Play ItStock Trading Terms – Stock Terms Every Investor Needs to KnowBuffett Trims Equities, But Still Keeps Buying This Stock Want to see what other hedge funds are holding AZTR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Azitra, Inc. (NYSEAMERICAN:AZTR – Free Report).
.
